News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Viatris Completes Acquisition of Aculys Pharma, Gaining Exclusive Rights to Pitolisant and Spydia® in Japan and Select Asia-Pacific Markets
Thursday, October 16, 2025Viatris Inc Nasdaq VTRS a global healthcare company has completed the acquisition of Aculys Pharma Inc a clinicalstage biopharmaceutical company focused on treatments for neurological conditions
Insitro Extends Collaboration with Bristol Myers Squibb Using ChemML™ Platform
Wednesday, October 15, 2025Insitro a company specialising in machine learningdriven drug discovery has extended its collaboration with Bristol Myers Squibb NYSE BMY to discover new molecules for treating amyotrophic lateral sclerosis ALS
Lundbeck’s Bexicaserin Granted Breakthrough Therapy Designation in China for Treating Seizures in Severe Rare Epilepsies
Tuesday, October 14, 2025Lundbeck has announced that its investigational drug bexicaserin has received Breakthrough Therapy Designation BTD from Chinas Center for Drug Evaluation CDE for the treatment of seizures linked to Developmental and Epileptic Encephalopathies DEEs
Adcendo’s ADCE-D01 Receives FDA Fast Track Designation for Soft Tissue Sarcoma
Friday, October 10, 2025Adcendo ApS a biotechnology company developing antibodydrug conjugates ADCs for cancers with high unmet medical need has announced that the US Food and Drug Administration FDA has granted Fast
Complement Therapeutics Secures FDA IND Clearance for CTx001 in Phase I/II Opti-GAIN Trial for Geographic Atrophy
Thursday, October 09, 2025Complement Therapeutics GmbH CTx a biotechnology company focused on complementmediated diseases has received Investigational New Drug IND clearance from the US Food and Drug Administration FDA
Precision NeuroMed Receives FDA Orphan Drug Designation for Glioblastoma Treatment
Thursday, October 09, 2025Precision NeuroMed PNM a clinicalstage biotechnology company developing advanced drug delivery technologies for central nervous system CNS disorders has received Orphan Drug Designation
Zenas BioPharma Secures Global Rights for Three Autoimmune Candidates, Including Orelabrutinib for Progressive MS
Wednesday, October 08, 2025Zenas BioPharma Incand InnoCare Pharma Limited have announced a licence agreement granting Zenas global development and commercialisation rights to orelabrutinib for multiple sclerosis MS and rights to develop
Lonza Expands TheraPEAK® Portfolio with AmpliCell® Cytokine Range and 293-GT® Medium
Tuesday, October 07, 2025Lonza one of the worlds leading contract development and manufacturing organisations CDMOs has announced the expansion of its TheraPEAK portfolio with the launch of AmpliCell Cytokines and TheraPEAK GT Medium further strengthening its GMPgrade soluti...
BenchSci forms strategic partnership with Thermo Fisher Scientific to deliver AI-powered research tools
Wednesday, October 01, 2025BenchSci has entered a strategic partnership with Thermo Fisher Scientific to develop AIpowered tools aimed at improving experimental design and increasing RD productivity in preclinical research and drug discovery
